University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

Researchers at the Markey Cancer Center have made an important discovery that could lead to new treatments for ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...

University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.

Two cycles of dual neoadjuvant immunotherapy (nivolumab/ipilimumab or nivolumab/relatlimab) induced high pathological ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...

There isn't enough evidence to support the use of Merck & Co/MSD's Keytruda in combination with chemotherapy as a first-line treatment for advanced triple negative breast cancer, according to the ...

Kashaf Shaikh, a young mother, faced a daunting challenge when she was diagnosed with triple-negative breast cancer while ...